Friend or foe: assessing the value of animal models for facilitating clinical breakthroughs in complement research
Journal of Clinical Investigation · 16.06.2025 · 135 (12)
DOI: 10.1172/jci188347 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Investigation, online erschienen am 16.06.2025. Verfasst von Felix Poppelaars und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: Complement System Proteins, Disease Models, Animal, Autoimmune Diseases, Biomedical Research. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 368 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIAMS NIH HHS.
Abstract (Originalsprache)
Animal experiments have long been a cornerstone of advancements in biomedical research, particularly in developing novel therapeutic strategies for inflammatory and autoimmune diseases. However, these historically important approaches are now facing growing scrutiny for ethical reasons, concerns about translational limitations to human biology, and the rising availability of animal-free research methods. This shift raises a critical question: How relevant and effective are animal models for driving future advancements in today’s research landscape? This Review aims to explore this question within the field of biomedical research on the complement system, critically evaluating the contribution of animal models to the recent advancements and clinical successes of complement-targeted therapies. Specifically, we assess areas where animal studies have been indispensable for elucidating disease mechanisms and conducting preclinical evaluations, alongside instances where findings from animal models failed to translate successfully to human trials. Furthermore, we discuss similarities and differences in the complement system between animals and humans and explore innovations in animal research designed to improve translatability to human biology. By assessing the contributions of animal studies to complement therapeutics, this Review aims to provide insights into animal models’ strengths, limitations, and evolving role in complement research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Förderung
- NIDDK NIH HHS
- NIAMS NIH HHS
Zitieren
APA
Poppelaars, F., Holers, V. M., & Thurman, J. M. (2025). Friend or foe: assessing the value of animal models for facilitating clinical breakthroughs in complement research. Journal of Clinical Investigation, 135(12). https://doi.org/10.1172/jci188347
Vancouver
Poppelaars F, Holers VM, Thurman JM. Friend or foe: assessing the value of animal models for facilitating clinical breakthroughs in complement research. Journal of Clinical Investigation. 2025;135(12). doi:10.1172/jci188347
BibTeX
@article{Poppelaars2025,
author = {Poppelaars, Felix and Holers, V Michael and Thurman, Joshua M},
title = {Friend or foe: assessing the value of animal models for facilitating clinical breakthroughs in complement research},
journal = {Journal of Clinical Investigation},
year = {2025},
volume = {135},
number = {12},
doi = {10.1172/jci188347}
}
EUVIMED